Literature DB >> 22157333

Lymphocytic oesophagitis: clinicopathological aspects of an emerging condition.

Salima Haque1, Robert M Genta.   

Abstract

OBJECTIVE: Lymphocytic oesophagitis (LyE) has been reported in small series, but no consistent clinical correlations have emerged. The authors sought to determine the prevalence of LyE in a large population and define demographic, endoscopic and clinical findings associated with this condition.
DESIGN: In a pilot study, the authors established and disseminated criteria for the histopathological diagnosis of LyE to a group of gastrointestinal pathologists. Eighteen months later the authors reviewed cases with this diagnosis, collected demographic, clinical and endoscopic data, and compared them with patients with either eosinophilic oesophagitis (EoE) or normal oesophageal biopsies. The authors also determined the density of oesophageal lymphocytes in normal controls and in adults with established Crohn's disease.
RESULTS: There were 129,252 unique PATIENTS: 40,665 had normal mucosa (median age 55 years; 32% men); 3745 had EoE (median age 43 years; 66% men). A diagnosis of LyE was made in 119 patients (median age 63 years, 40% men). Dysphagia was as common in these patients as in those with EoE (53% vs 63%; ns); gastro-oesophageal reflux disease -the most common complaint in patients with normal biopsies (37%)-was low in both the LyE and the EoE groups (18% vs 19%, ns). EoE was suspected in one-third of the patients.
CONCLUSION: LyE was detected in ∼0.1% of patients with oesophageal biopsies. The clinical and endoscopic characteristics of LyE and EoE overlap considerably; however, LyE affects predominantly older women. Although the precise clinical significance of oesophageal lymphocytic infiltrates remain to be defined, their association with dysphagia and possibly motility disorders warrants further investigations.

Entities:  

Mesh:

Year:  2011        PMID: 22157333     DOI: 10.1136/gutjnl-2011-301014

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

Review 1.  How to Approach Lymphocytic Esophagitis.

Authors:  Anh D Nguyen; Kerry B Dunbar
Journal:  Curr Gastroenterol Rep       Date:  2017-06

2.  [Gastroenterological diseases as triggers of chest pain].

Authors:  J Labenz; C Labenz
Journal:  Internist (Berl)       Date:  2017-01       Impact factor: 0.743

3.  Another New Esophagitis: The Lymphocyte Gets Its Turn.

Authors:  David A Katzka
Journal:  Dig Dis Sci       Date:  2016-10       Impact factor: 3.199

4.  Lymphocytic Esophagitis.

Authors:  Robert M Genta
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-08

5.  Post-ablation lymphocytic esophagitis in Barrett esophagus with high grade dysplasia or intramucosal carcinoma.

Authors:  Juliana Kissiedu; Prashanthi N Thota; Tushar Gohel; Rocio Lopez; Ilyssa O Gordon
Journal:  Mod Pathol       Date:  2016-03-11       Impact factor: 7.842

6.  Diagnosing Gastroesophageal Reflux Disease With Endoscopic-Guided Mucosal Impedance.

Authors:  Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-04

7.  Ringed Esophagus Secondary to Lymphocytic Esophagitis.

Authors:  Ze Zhang; Dhanpat Jain; Myron Brand
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-04

8.  Lymphocytic Esophagitis in Nonachalasia Primary Esophageal Motility Disorders: Improved Criteria, Prevalence, Strength of Association, and Natural History.

Authors:  Juan Putra; Kristen E Muller; Zilla H Hussain; Siddhartha Parker; Scott Gabbard; Elizabeth B Brickley; Brian E Lacy; Richard Rothstein; Mikhail Lisovsky
Journal:  Am J Surg Pathol       Date:  2016-12       Impact factor: 6.394

Review 9.  [Lymphocytic esophagitis: an entity to be excluded in chronic inflammatory diseases of the esophagus].

Authors:  L Veits; J Drgac; R J Rieker
Journal:  Pathologe       Date:  2013-03       Impact factor: 1.011

10.  Lymphocytic Esophagitis: An Emerging Clinicopathologic Disease Associated with Dysphagia.

Authors:  Sarina Pasricha; Amit Gupta; Craig C Reed; Olga Speck; John T Woosley; Evan S Dellon
Journal:  Dig Dis Sci       Date:  2016-06-24       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.